Skip to content

CABALETTA BIO, INC.

CABA

CIK 0001759138

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$169.45M
−44.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.27
+10.3% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$111.94M
Q1 May 2026
Cash
$116.64M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
163.05M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings